Homology Medicines (BATS:FIXX) CEO Sells 9,845 Shares

Homology Medicines, Inc. (BATS:FIXX) CEO Jodie Pope Morrison sold 9,845 shares of Homology Medicines stock in a transaction dated Tuesday, August 25th. The shares were sold at an average price of $16.56, for a total value of $163,033.20. Following the transaction, the chief executive officer directly owned 343,259 shares in the company, valued at approximately $5,684,369.04. This trade represents a 2.79% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Homology Medicines Stock Performance

Shares of FIXX traded up $0.02 during trading hours on Thursday, reaching $12.90. The company’s stock had a trading volume of 978 shares.

Homology Medicines, Inc was a clinical-stage biotechnology company focused on developing genetic medicines for patients with rare diseases. The company sought to use its proprietary human-derived adeno-associated virus vectors, known as AAVHSCs, to deliver gene therapies in vivo and address the underlying causes of inherited disorders.

Its development programs included HMI-103, an investigational gene therapy for phenylketonuria, as well as earlier programs targeting other rare diseases.